Table III.
Sequence Analysis From 12 Subjects With Discordant PCR/ESI‐MS and DFA Results
| Subject ID | PCR/ESI‐MS | DFA | PCR/sequencing |
|---|---|---|---|
| #1 (10–744) | RSV, PIV3 | RSV | RSV, PIV3 |
| #2 (10–1103) | INFB, Adenovirus, PIV1 | PIV1 | Adenovirus, PIV1 |
| #3 (10–1134) | RSV, PIV3 | RSV | RSV, PIV3 |
| #4 (10–1184) | PIV3 | Adenovirus | PIV3 |
| #5 (10–1200) | hMPV | hMPV, Adenovirus | hMPV |
| #6 (11–84) | RSV, IFNA, Adenovirus | Adenovirus | RSV, INFA, Adenovirus |
| #7 (11–150) | RSV, PIV3 | RSV | RSV, PIV3 |
| #8 (11–156) | RSV, hMPV | RSV | RSV, hMPV |
| #9 (11–246) | Adenovirus, INFA | Adenovirus | Adenovirus, INFA |
| #10 (11–552) | RSV, Adenovirus | RSV | RSV, Adenovirus |
| #11 (11–72) | INFA | (−) | INFA |
| #12 (11–78) | RSV | (−) | RSV |
RSV, Respiratory syncytial virus; PIV1, Parainfluenza virus 1; PIV2, Parainfluenza virus 2; PIV3, Parainfluenza virus 3; INFA, Influenza virus A; INFB, Influenza virus B; hMPV, human Metapneumovirus.
Ten subjects from No.1–10 were the samples with multiple viruses detected by RT‐PCR/ESI‐MS or DFA.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.